Skip to main navigation
Skip to search
Skip to main content
Augusta University Research Profiles Home
Help & FAQ
Home
Profiles
Research units
Equipment
Grants
Scholarly Output
Activities
Prizes
Search by expertise, name or affiliation
FDA-Approved Medications to Treat Tardive Dyskinesia
Joseph P. McEvoy
Psychiatry and Health Behavior
Research output
:
Contribution to journal
›
Review article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'FDA-Approved Medications to Treat Tardive Dyskinesia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Tardive Dyskinesia
100%
deutetrabenazine
29%
valbenazine
29%
Dopamine Receptors
17%
Medication Adherence
16%
Dyskinesias
16%
Antipsychotic Agents
13%
Therapeutics
9%
Quality of Life
9%
Guidelines
9%